Published in Nature on July 19, 2012
Role of Immune Responses After Acute Myocardial Infarction (BATTLE-AMI) | NCT02428374
Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat Med (2013) 4.14
Macrophages in atherosclerosis: a dynamic balance. Nat Rev Immunol (2013) 3.85
Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science (2013) 3.22
Immune effector mechanisms implicated in atherosclerosis: from mice to humans. Immunity (2013) 2.37
The not-so-simple HDL story: Is it time to revise the HDL cholesterol hypothesis? Nat Med (2012) 2.31
Angiotensin II drives the production of tumor-promoting macrophages. Immunity (2013) 1.88
Monocyte subset accumulation in the human heart following acute myocardial infarction and the role of the spleen as monocyte reservoir. Eur Heart J (2013) 1.83
Cholesterol, inflammation and innate immunity. Nat Rev Immunol (2015) 1.72
Chronic variable stress activates hematopoietic stem cells. Nat Med (2014) 1.70
Monocyte and macrophage heterogeneity in the heart. Circ Res (2013) 1.63
Recent insights into the cellular biology of atherosclerosis. J Cell Biol (2015) 1.60
A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation. Nat Commun (2014) 1.58
Involvement of bone marrow cells and neuroinflammation in hypertension. Circ Res (2015) 1.54
Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function. J Mol Cell Cardiol (2015) 1.54
Genetic Architecture of Atherosclerosis in Mice: A Systems Genetics Analysis of Common Inbred Strains. PLoS Genet (2015) 1.52
Experimental coronary artery stenosis accelerates kidney damage in renovascular hypertensive swine. Kidney Int (2014) 1.48
The arachidonic acid metabolome serves as a conserved regulator of cholesterol metabolism. Cell Metab (2014) 1.47
Inflammatory processes in cardiovascular disease: a route to targeted therapies. Nat Rev Cardiol (2016) 1.46
Splenocytes seed bone marrow of myeloablated mice: implication for atherosclerosis. PLoS One (2015) 1.40
Unexpected arterial wall and cellular inflammation in patients with rheumatoid arthritis in remission using biological therapy: a cross-sectional study. Arthritis Res Ther (2016) 1.40
Arterial Effects of Canakinumab in Patients With Atherosclerosis and Type 2 Diabetes or Glucose Intolerance. J Am Coll Cardiol (2016) 1.40
Cholesterol efflux in megakaryocyte progenitors suppresses platelet production and thrombocytosis. Nat Med (2013) 1.36
The spleen in local and systemic regulation of immunity. Immunity (2013) 1.33
Monocyte-directed RNAi targeting CCR2 improves infarct healing in atherosclerosis-prone mice. Circulation (2013) 1.30
Enhanced efferocytosis of apoptotic cardiomyocytes through myeloid-epithelial-reproductive tyrosine kinase links acute inflammation resolution to cardiac repair after infarction. Circ Res (2013) 1.27
Endoscopic time-lapse imaging of immune cells in infarcted mouse hearts. Circ Res (2013) 1.26
Mechanisms that regulate macrophage burden in atherosclerosis. Circ Res (2014) 1.26
Imaging and nanomedicine in inflammatory atherosclerosis. Sci Transl Med (2014) 1.23
Cardiac macrophages and their role in ischaemic heart disease. Cardiovasc Res (2014) 1.21
Re-establishment of anxiety in stress-sensitized mice is caused by monocyte trafficking from the spleen to the brain. Biol Psychiatry (2013) 1.18
Proliferating macrophages prevail in atherosclerosis. Nat Med (2013) 1.12
Monocyte trafficking to the brain with stress and inflammation: a novel axis of immune-to-brain communication that influences mood and behavior. Front Neurosci (2015) 1.08
Role of miR-181 family in regulating vascular inflammation and immunity. Trends Cardiovasc Med (2013) 1.06
Macrophages retain hematopoietic stem cells in the spleen via VCAM-1. J Exp Med (2015) 1.06
Monocyte heterogeneity in cardiovascular disease. Semin Immunopathol (2013) 1.05
Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions. Eur Heart J (2014) 1.04
The CXCL12/CXCR4 chemokine ligand/receptor axis in cardiovascular disease. Front Physiol (2014) 1.03
Monocytes in myocardial infarction. Arterioscler Thromb Vasc Biol (2015) 1.03
The advancing clinical impact of molecular imaging in CVD. JACC Cardiovasc Imaging (2013) 1.01
Ischemic stroke activates hematopoietic bone marrow stem cells. Circ Res (2014) 1.00
Inhibiting macrophage proliferation suppresses atherosclerotic plaque inflammation. Sci Adv (2015) 0.99
Proliferation and Recruitment Contribute to Myocardial Macrophage Expansion in Chronic Heart Failure. Circ Res (2016) 0.99
Leukocytes Link Local and Systemic Inflammation in Ischemic Cardiovascular Disease: An Expanded "Cardiovascular Continuum". J Am Coll Cardiol (2016) 0.97
Sympathetic nervous system regulation of the tumour microenvironment. Nat Rev Cancer (2015) 0.96
Niche heterogeneity in the bone marrow. Ann N Y Acad Sci (2016) 0.96
Acute myocardial infarction is associated with endothelial glycocalyx and cell damage and a parallel increase in circulating catecholamines. Crit Care (2013) 0.96
Interleukin-3/granulocyte macrophage colony-stimulating factor receptor promotes stem cell expansion, monocytosis, and atheroma macrophage burden in mice with hematopoietic ApoE deficiency. Arterioscler Thromb Vasc Biol (2014) 0.96
Myocardial Infarction Activates CCR2(+) Hematopoietic Stem and Progenitor Cells. Cell Stem Cell (2015) 0.96
Collagenases and cracks in the plaque. J Clin Invest (2013) 0.96
Tracking of intertissue migration reveals the origins of tumor-infiltrating monocytes. Proc Natl Acad Sci U S A (2014) 0.95
Concise review: diabetes, the bone marrow niche, and impaired vascular regeneration. Stem Cells Transl Med (2014) 0.95
Arterial disease in patients with human immunodeficiency virus infection: what has imaging taught us? JACC Cardiovasc Imaging (2014) 0.95
Targeting Interleukin-1β Reduces Leukocyte Production After Acute Myocardial Infarction. Circulation (2015) 0.94
Hypercholesterolemia links hematopoiesis with atherosclerosis. Trends Endocrinol Metab (2012) 0.94
From proliferation to proliferation: monocyte lineage comes full circle. Semin Immunopathol (2014) 0.93
Systemic inflammatory response following acute myocardial infarction. J Geriatr Cardiol (2015) 0.93
Altered inflammatory response is associated with an impaired autonomic input to the bone marrow in the spontaneously hypertensive rat. Hypertension (2013) 0.93
The role of myeloid cells in cancer therapies. Nat Rev Cancer (2016) 0.92
ST elevation acute myocardial infarction accelerates non-culprit coronary lesion atherosclerosis. Int J Cardiovasc Imaging (2014) 0.92
Noninvasive Molecular Imaging of Disease Activity in Atherosclerosis. Circ Res (2016) 0.92
A perisinusoidal niche for extramedullary haematopoiesis in the spleen. Nature (2015) 0.91
Platelets and their chemokines in atherosclerosis-clinical applications. Front Physiol (2014) 0.91
Depression and cardiovascular disease: an update on how course of illness may influence risk. Curr Psychiatry Rep (2014) 0.91
Macrophages in vascular inflammation--From atherosclerosis to vasculitis. Autoimmunity (2015) 0.91
Neural regulation of cancer: from mechanobiology to inflammation. Clin Transl Immunology (2016) 0.90
Beyond vascular inflammation--recent advances in understanding atherosclerosis. Cell Mol Life Sci (2015) 0.90
Systems Biology Approaches and Applications in Obesity, Diabetes, and Cardiovascular Diseases. Curr Cardiovasc Risk Rep (2012) 0.89
Cardiovascular and mortality risk of apparent resistant hypertension in women with suspected myocardial ischemia: a report from the NHLBI-sponsored WISE Study. J Am Heart Assoc (2014) 0.89
Acute myocardial infarction leads to acceleration of atherosclerosis. Atherosclerosis (2013) 0.88
Sympathetic Release of Splenic Monocytes Promotes Recurring Anxiety Following Repeated Social Defeat. Biol Psychiatry (2015) 0.88
Cerebral ischemia increases bone marrow CD4+CD25+FoxP3+ regulatory T cells in mice via signals from sympathetic nervous system. Brain Behav Immun (2014) 0.88
Hypercholesterolemia induces oxidant stress that accelerates the ageing of hematopoietic stem cells. J Am Heart Assoc (2014) 0.88
The innate immune system after ischemic injury: lessons to be learned from the heart and brain. JAMA Neurol (2014) 0.87
Silencing of CCR2 in myocarditis. Eur Heart J (2014) 0.86
Cardiovascular toxicity of nicotine: Implications for electronic cigarette use. Trends Cardiovasc Med (2016) 0.85
LDL cholesterol modulates human CD34+ HSPCs through effects on proliferation and the IL-17 G-CSF axis. PLoS One (2013) 0.85
Disordered haematopoiesis and athero-thrombosis. Eur Heart J (2016) 0.85
Is the risk of cardiovascular disease altered with anti-inflammatory therapies? Insights from rheumatoid arthritis. Clin Transl Immunology (2016) 0.84
Imaging systemic inflammatory networks in ischemic heart disease. J Am Coll Cardiol (2015) 0.84
Modulation of mononuclear phagocyte inflammatory response by liposome-encapsulated voltage gated sodium channel inhibitor ameliorates myocardial ischemia/reperfusion injury in rats. PLoS One (2013) 0.84
Interplay of NK cells and monocytes in vascular inflammation and myocardial infarction. Front Physiol (2014) 0.84
Role of CD11b+Gr-1+ myeloid cells in AGEs-induced myocardial injury in a mice model of acute myocardial infarction. Int J Clin Exp Pathol (2015) 0.83
Lifestyle effects on hematopoiesis and atherosclerosis. Circ Res (2015) 0.83
NLRP3 Inflammasome Expression and Activation in Human Atherosclerosis. J Am Heart Assoc (2016) 0.83
Angiotensinogen Exerts Effects Independent of Angiotensin II. Arterioscler Thromb Vasc Biol (2015) 0.83
Plasma leptin level is associated with cardiac autonomic dysfunction in patients with type 2 diabetes: HSCAA study. Cardiovasc Diabetol (2015) 0.82
RNAi targeting multiple cell adhesion molecules reduces immune cell recruitment and vascular inflammation after myocardial infarction. Sci Transl Med (2016) 0.82
Extrarenal atherosclerotic disease blunts renal recovery in patients with renovascular hypertension. J Hypertens (2014) 0.82
Brain-Gut-Bone Marrow Axis: Implications for Hypertension and Related Therapeutics. Circ Res (2016) 0.82
Atrial fibrillation is associated with hematopoietic tissue activation and arterial inflammation. Int J Cardiovasc Imaging (2015) 0.82
Functional neural-bone marrow pathways: implications in hypertension and cardiovascular disease. Hypertension (2014) 0.81
Direct Imaging of Cerebral Thromboemboli Using Computed Tomography and Fibrin-targeted Gold Nanoparticles. Theranostics (2015) 0.81
The journey from stem cell to macrophage. Ann N Y Acad Sci (2014) 0.81
Effects of dyslipidaemia on monocyte production and function in cardiovascular disease. Nat Rev Cardiol (2017) 0.81
Innate immune cells in ischaemic heart disease: does myocardial infarction beget myocardial infarction? Eur Heart J (2015) 0.81
Cardiology: Bad matters made worse. Nature (2012) 0.81
Phagocyte-myocyte interactions and consequences during hypoxic wound healing. Cell Immunol (2014) 0.80
Association of Matrix Metalloproteinase 9 C-1562T Polymorphism with Genetic Susceptibility to Myocardial Infarction: A Meta-Analysis. Curr Ther Res Clin Exp (2015) 0.80
Spleen supports a pool of innate-like B cells in white adipose tissue that protects against obesity-associated insulin resistance. Proc Natl Acad Sci U S A (2014) 0.80
2013 Thomas Willis Award Lecture: Causation and collaboration for stroke research. Stroke (2013) 0.80
Inflammation in atherosclerosis. Nature (2002) 28.92
Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med (2004) 19.42
Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature (2010) 15.28
Development of monocytes, macrophages, and dendritic cells. Science (2010) 12.86
The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med (2007) 11.51
The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med (2006) 10.99
Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science (2009) 10.47
Progress and challenges in translating the biology of atherosclerosis. Nature (2011) 9.41
Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest (2007) 9.09
Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J Clin Invest (2007) 8.65
Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu Rev Immunol (2002) 7.78
Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest (1994) 7.25
Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell (2006) 7.23
Pathophysiology of coronary artery disease. Circulation (2005) 6.65
Live-animal tracking of individual haematopoietic stem/progenitor cells in their niche. Nature (2008) 6.61
Endothelial and perivascular cells maintain haematopoietic stem cells. Nature (2012) 6.60
Haematopoietic stem cell release is regulated by circadian oscillations. Nature (2008) 6.50
Immune and inflammatory mechanisms of atherosclerosis (*). Annu Rev Immunol (2009) 5.28
Atherosclerosis: current pathogenesis and therapeutic options. Nat Med (2011) 4.95
Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med (2000) 3.70
Monocytes: protagonists of infarct inflammation and repair after myocardial infarction. Circulation (2010) 3.37
Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis. J Exp Med (2012) 2.92
In vivo imaging of proteolytic activity in atherosclerosis. Circulation (2002) 2.62
Fibronectin and VLA-4 in haematopoietic stem cell-microenvironment interactions. Nature (1991) 2.53
Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood (2004) 2.52
Extramedullary hematopoiesis generates Ly-6C(high) monocytes that infiltrate atherosclerotic lesions. Circulation (2011) 2.45
Hybrid in vivo FMT-CT imaging of protease activity in atherosclerosis with customized nanosensors. Arterioscler Thromb Vasc Biol (2009) 2.15
Leukocytes and the risk of ischemic diseases. JAMA (1987) 2.03
Comparative pharmacology of human beta-adrenergic receptor subtypes--characterization of stably transfected receptors in CHO cells. Naunyn Schmiedebergs Arch Pharmacol (2004) 1.95
Identification of a monocyte-predisposed hierarchy of hematopoietic progenitor cells in the adventitia of postnatal murine aorta. Circulation (2011) 1.84
The haematopoietic stem cell niche at a glance. J Cell Sci (2011) 1.63
Effect of Angiotensin-converting enzyme inhibition on one-year mortality and frequency of repeat acute myocardial infarction in patients with acute myocardial infarction. Am J Cardiol (2010) 1.20
The fate of monocytes in atherosclerosis. J Thromb Haemost (2009) 1.09
Electrical stimulation of preganglionic nerve increases tyrosine hydroxylase activity in sympathetic ganglia. Proc Natl Acad Sci U S A (1977) 1.03
Alterations in cytokine and antibody production following chemical sympathectomy in two strains of mice. J Immunol (1995) 1.00
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med (2008) 43.36
Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med (2007) 17.85
Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers. Nat Med (2008) 14.47
Restoration of p53 function leads to tumour regression in vivo. Nature (2007) 12.62
Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell (2008) 12.29
Universal definition of myocardial infarction. Circulation (2007) 11.69
Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol (2005) 11.63
The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med (2007) 11.51
Imaging in the era of molecular oncology. Nature (2008) 11.10
Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet (2009) 10.52
Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science (2009) 10.47
The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol (2006) 9.61
Looking and listening to light: the evolution of whole-body photonic imaging. Nat Biotechnol (2005) 9.57
Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA (2006) 9.27
Cytochrome p-450 polymorphisms and response to clopidogrel. N Engl J Med (2008) 9.25
Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature (2006) 9.20
Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med (2003) 9.09
Consensus statement on the pathology of IgG4-related disease. Mod Pathol (2012) 9.01
Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA (2002) 8.81
Long-term use of ticagrelor in patients with prior myocardial infarction. N Engl J Med (2015) 8.69
Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J Clin Invest (2007) 8.65
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation (2003) 8.61
Third universal definition of myocardial infarction. J Am Coll Cardiol (2012) 8.59
Third universal definition of myocardial infarction. Circulation (2012) 8.47
Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis. JAMA (2011) 8.24
Third universal definition of myocardial infarction. Eur Heart J (2012) 7.98
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2012) 7.94
Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med (2013) 7.70
Clopidogrel with or without omeprazole in coronary artery disease. N Engl J Med (2010) 7.39
Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism. Cell (2012) 7.36
Rivaroxaban in patients with a recent acute coronary syndrome. N Engl J Med (2011) 7.30
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2012) 6.94
Live-animal tracking of individual haematopoietic stem/progenitor cells in their niche. Nature (2008) 6.61
In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment. Nature (2005) 6.60
Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci (2003) 6.53
Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis. JAMA (2010) 6.29
Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA (2010) 6.11
Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging. Eur Radiol (2002) 6.06
Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo. Mol Ther (2005) 6.04
Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy. N Engl J Med (2015) 6.00
Chemical imaging of tissue in vivo with video-rate coherent anti-Stokes Raman scattering microscopy. Proc Natl Acad Sci U S A (2005) 5.96
Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse. Proc Natl Acad Sci U S A (2006) 5.90
A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med (2009) 5.81
Fluorescence molecular tomography resolves protease activity in vivo. Nat Med (2002) 5.53
The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies. Cancer Cell (2006) 5.34
Arthritis critically dependent on innate immune system players. Immunity (2002) 5.31
Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell (2002) 5.11
The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha. Cell (2010) 5.11
Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med (2002) 4.86
Endogenous bone marrow MSCs are dynamic, fate-restricted participants in bone maintenance and regeneration. Cell Stem Cell (2012) 4.67
Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia. Proc Natl Acad Sci U S A (2005) 4.63
The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science (2013) 4.60
2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2014) 4.57
Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial. Lancet (2012) 4.46
A randomized trial of rosuvastatin in the prevention of venous thromboembolism. N Engl J Med (2009) 4.46
Hypertrophy of the heart: a new therapeutic target? Circulation (2004) 4.45
Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction. Nat Immunol (2007) 4.41
Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials. Lancet (2009) 4.31
Chip-NMR biosensor for detection and molecular analysis of cells. Nat Med (2008) 4.29
Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum (2012) 4.27
SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells. Nat Med (2012) 4.27
Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo. Circulation (2007) 4.20
The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat Rev Immunol (2008) 4.20
Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy. J Am Coll Cardiol (2006) 4.16
Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat Med (2013) 4.14
Magnetic relaxation switches capable of sensing molecular interactions. Nat Biotechnol (2002) 4.13
Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo. Proc Natl Acad Sci U S A (2004) 4.12
Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy. Nat Med (2012) 4.11
Vorapaxar in the secondary prevention of atherothrombotic events. N Engl J Med (2012) 4.10
Diabetes and mortality following acute coronary syndromes. JAMA (2007) 4.09
Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem (2008) 4.08
HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial. Lancet (2010) 4.07
MicroRNA-34a regulates cardiac ageing and function. Nature (2013) 4.03
Clinical and pathophysiological implications of a bicuspid aortic valve. Circulation (2002) 3.98